{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T05:40:36Z","timestamp":1772516436387,"version":"3.50.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11033-023-08759-w","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T17:01:53Z","timestamp":1693328513000},"page":"8575-8587","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Investigating the relationship between the VNTR variant of the interleukin-1 receptor antagonist gene and coronary in-stent restenosis"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6241-0692","authenticated-orcid":false,"given":"Zeynab Nickhah","family":"Klashami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atoosa","family":"Mostafavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7941-4959","authenticated-orcid":false,"given":"Majid Gholamzadeh","family":"Roudbordeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1929-9535","authenticated-orcid":false,"given":"Ali","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pirooz","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5911-1782","authenticated-orcid":false,"given":"Mojgan","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9168-9223","authenticated-orcid":false,"given":"Mahsa M.","family":"Amoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,29]]},"reference":[{"key":"8759_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-908517-26-5","volume-title":"Indications and techniques of percutaneous procedures: coronary\u00a0peripheral and structural heart disease","author":"AAK Bavry","year":"2012","unstructured":"Bavry AAK, Khumbhani DJ (2012) Indications and techniques of percutaneous procedures: coronary\u00a0peripheral and structural heart disease. Springer, Heidelberg"},{"issue":"19","key":"8759_CR2","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1056\/NEJMc060570","volume":"354","author":"DP Taggart","year":"2006","unstructured":"Taggart DP (2006) Coronary-artery stents. N Engl J Med 354(19):2076\u20132078","journal-title":"N Engl J Med"},{"issue":"7398","key":"8759_CR3","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1136\/bmj.326.7398.1080","volume":"326","author":"ED Grech","year":"2003","unstructured":"Grech ED (2003) ABC of interventional cardiology: percutaneous coronary intervention. I: history and development. BMJ 326(7398):1080\u20131082","journal-title":"BMJ"},{"issue":"4","key":"8759_CR4","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/path.1598","volume":"203","author":"MS Lee","year":"2004","unstructured":"Lee MS, David EM, Makkar RR, Wilentz JR (2004) Molecular and cellular basis of restenosis after percutaneous coronary intervention: the intertwining roles of platelets, leukocytes, and the coagulation-fibrinolysis system. J Pathol 203(4):861\u2013870","journal-title":"J Pathol"},{"issue":"3","key":"8759_CR5","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1136\/jcp.2005.025742","volume":"59","author":"AK Mitra","year":"2006","unstructured":"Mitra AK, Agrawal DK (2006) In stent restenosis: bane of the stent era. J Clin Pathol 59(3):232\u2013239","journal-title":"J Clin Pathol"},{"issue":"7","key":"8759_CR6","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/01.CIR.99.7.861","volume":"99","author":"SE Francis","year":"1999","unstructured":"Francis SE, Camp NJ, Dewberry RM, Gunn J, Syrris P, Carter ND et al (1999) Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 99(7):861\u2013866","journal-title":"Circulation"},{"issue":"1","key":"8759_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0167-5699(90)90005-T","volume":"11","author":"FS di Giovine","year":"1990","unstructured":"di Giovine FS, Duff GW (1990) Interleukin 1: the first interleukin. Immunol Today 11(1):13\u201320","journal-title":"Immunol Today"},{"issue":"8652","key":"8759_CR8","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/S0140-6736(89)90134-7","volume":"1","author":"GW Duff","year":"1989","unstructured":"Duff GW (1989) Peptide regulatory factors in non-malignant disease. Lancet 1(8652):1432\u20131435","journal-title":"Lancet"},{"issue":"8","key":"8759_CR9","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1161\/01.ATV.16.8.1000","volume":"16","author":"J Galea","year":"1996","unstructured":"Galea J, Armstrong J, Gadsdon P, Holden H, Francis SE, Holt CM (1996) Interleukin-1 beta in coronary arteries of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol 16(8):1000\u20131006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"8759_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0002-9149(90)90291-8","volume":"65","author":"P Barath","year":"1990","unstructured":"Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS (1990) Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 65(5):297\u2013302","journal-title":"Am J Cardiol"},{"key":"8759_CR11","unstructured":"Markers for metabolic syndrome obesity and, insulin resistance drcu (2006) 01). Markers for metabolic syndrome obesity and insulin resistance, David R. Cox (US), (2006.01). Cox (US),. 2006"},{"issue":"4","key":"8759_CR12","doi-asserted-by":"publisher","first-page":"e0153480","DOI":"10.1371\/journal.pone.0153480","volume":"11","author":"H Rai","year":"2016","unstructured":"Rai H, Sinha N, Kumar S, Sharma AK, Agrawal S (2016) Interleukin-1 gene cluster polymorphisms and their association with coronary artery disease: separate evidences from the Largest Case-Control Study amongst North Indians and an updated Meta-analysis. PLoS ONE 11(4):e0153480","journal-title":"PLoS ONE"},{"issue":"5","key":"8759_CR13","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3390\/jcm10050990","volume":"10","author":"T Rechci\u0144ski","year":"2021","unstructured":"Rechci\u0144ski T, Szyma\u0144ska B, Wierzbowska-Drabik K, Chmiela M, Matusiak A, Kurpesa M et al (2021) Polymorphism of Interleukin-1 gene cluster in polish patients with acute coronary syndrome. J Clin Med 10(5):990","journal-title":"J Clin Med"},{"issue":"1","key":"8759_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2261-5-10","volume":"5","author":"D Rothenbacher","year":"2005","unstructured":"Rothenbacher D, Brenner H, Mertens T, Hoffmann MM, Hoffmeister A, Koenig W (2005) Prognostic value of interleukin-1 receptor antagonist gene polymorphism and cytomegalovirus seroprevalence in patients with coronary artery disease. BMC Cardiovasc Disord 5(1):10","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"8759_CR15","doi-asserted-by":"publisher","first-page":"e22255","DOI":"10.1002\/jcla.22255","volume":"32","author":"MK Tumer","year":"2018","unstructured":"Tumer MK, Nursal AF, Tekcan A, Yerliyurt K, Geyko A, Yigit S (2018) The IL-1Ra gene variable number tandem repeat variant is associated with susceptibility to temporomandibular disorders in turkish population. J Clin Lab Anal 32(2):e22255","journal-title":"J Clin Lab Anal"},{"issue":"18","key":"8759_CR16","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1161\/01.CIR.100.18.1872","volume":"100","author":"R Mehran","year":"1999","unstructured":"Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF et al (1999) Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 100(18):1872\u20131878","journal-title":"Circulation"},{"issue":"6","key":"8759_CR17","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/1529-0131(199906)42:6<1093::AID-ANR5>3.0.CO;2-P","volume":"42","author":"A Cantagrel","year":"1999","unstructured":"Cantagrel A, Navaux F, Loubet-Lescouli\u00e9 P, Nourhashemi F, Enault G, Abbal M et al (1999) Interleukin\u20101\u03b2, interleukin\u20101 receptor antagonist, interleukin\u20104, and interleukin\u201010 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthr Rheum: Off J Am Coll Rheum 42(6):1093\u20131100","journal-title":"Arthr Rheum: Off J Am Coll Rheum"},{"issue":"2","key":"8759_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0735-1097(01)01742-9","volume":"39","author":"HC Lowe","year":"2002","unstructured":"Lowe HC, Oesterle SN, Khachigian LM (2002) Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol 39(2):183\u2013193","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"8759_CR19","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1365-2613.2009.00700.x","volume":"91","author":"S Shafi","year":"2010","unstructured":"Shafi S, Lamb D, Modjtahedi H, Ferns G (2010) Periadventitial delivery of anti-EGF receptor antibody inhibits neointimal macrophage accumulation after angioplasty in a hypercholesterolaemic rabbit. Int J Exp Pathol 91(3):224\u2013234","journal-title":"Int J Exp Pathol"},{"issue":"7347","key":"8759_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature10146","volume":"473","author":"P Libby","year":"2011","unstructured":"Libby P, Ridker PM, Hansson GK (2011) Progress and challenges in translating the biology of atherosclerosis. Nature 473(7347):317\u2013325","journal-title":"Nature"},{"key":"8759_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/2045-824X-6-21","volume":"6","author":"BP Herring","year":"2014","unstructured":"Herring BP, Hoggatt AM, Burlak C, Offermanns S (2014) Previously differentiated medial vascular smooth muscle cells contribute to neointima formation following vascular injury. Vasc cell 6:21","journal-title":"Vasc cell"},{"issue":"3","key":"8759_CR22","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1161\/01.CIR.98.3.224","volume":"98","author":"R Komatsu","year":"1998","unstructured":"Komatsu R, Ueda M, Naruko T, Kojima A, Becker AE (1998) Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses. Circulation 98(3):224\u2013233","journal-title":"Circulation"},{"issue":"10175","key":"8759_CR23","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0140-6736(18)32467-X","volume":"393","author":"A Zaman","year":"2019","unstructured":"Zaman A, de Winter RJ, Kogame N, Chang CC, Modolo R, Spitzer E et al (2019) Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial. Lancet 393(10175):987\u2013997","journal-title":"Lancet"},{"issue":"6423","key":"8759_CR24","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/362801a0","volume":"362","author":"R Ross","year":"1993","unstructured":"Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362(6423):801\u2013809","journal-title":"Nature"},{"issue":"1","key":"8759_CR25","first-page":"Ra5","volume":"8","author":"SM Saadeddin","year":"2002","unstructured":"Saadeddin SM, Habbab MA, Ferns GA (2002) Markers of inflammation and coronary artery disease. Med Sci Monitor: Int Med J Exp Clin Res 8(1):Ra5-12","journal-title":"Med Sci Monitor: Int Med J Exp Clin Res"},{"issue":"3","key":"8759_CR26","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/eji.201040319","volume":"40","author":"CA Dinarello","year":"2010","unstructured":"Dinarello CA (2010) IL-1: discoveries, controversies and future directions. Eur J Immunol 40(3):599\u2013606","journal-title":"Eur J Immunol"},{"issue":"105","key":"8759_CR27","first-page":"cm1","volume":"3","author":"A Weber","year":"2010","unstructured":"Weber A, Wasiliew P, Kracht M (2010) Interleukin-1 (IL-1) pathway. Sci Signal 3(105):cm1","journal-title":"Sci Signal"},{"issue":"1","key":"8759_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12621","volume":"281","author":"CA Dinarello","year":"2018","unstructured":"Dinarello CA (2018) Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev 281(1):8\u201327","journal-title":"Immunol Rev"},{"issue":"6","key":"8759_CR29","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","volume":"39","author":"C Garlanda","year":"2013","unstructured":"Garlanda C, Dinarello CA, Mantovani A (2013) The interleukin-1 family: back to the future. Immunity 39(6):1003\u20131018","journal-title":"Immunity"},{"issue":"2","key":"8759_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R (1999) Atherosclerosis\u2013an inflammatory disease. N Engl J Med 340(2):115\u2013126","journal-title":"N Engl J Med"},{"issue":"16","key":"8759_CR31","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352(16):1685\u20131695","journal-title":"N Engl J Med"},{"issue":"2","key":"8759_CR32","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1378\/chest.118.2.503","volume":"118","author":"CA Dinarello","year":"2000","unstructured":"Dinarello CA (2000) Proinflammatory cytokines. Chest 118(2):503\u2013508","journal-title":"Chest"},{"issue":"2","key":"8759_CR33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1172\/JCI113346","volume":"81","author":"P Libby","year":"1988","unstructured":"Libby P, Warner SJ, Friedman GB (1988) Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest 81(2):487\u2013498","journal-title":"J Clin Invest"},{"issue":"2","key":"8759_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1096\/fasebj.1.2.3111928","volume":"1","author":"J Vane","year":"1987","unstructured":"Vane J, Botting R (1987) Inflammation and the mechanism of action of anti-inflammatory drugs. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 1(2):89\u201396","journal-title":"FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology"},{"issue":"9","key":"8759_CR35","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2337\/dc09-0533","volume":"32","author":"CM Larsen","year":"2009","unstructured":"Larsen CM, Faulenbach M, Vaag A, Ehses JA, Donath MY, Mandrup-Poulsen T (2009) Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care 32(9):1663\u20131668","journal-title":"Diabetes Care"},{"issue":"3","key":"8759_CR36","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1365-2796.2010.02294.x","volume":"269","author":"K Luotola","year":"2011","unstructured":"Luotola K, Pietil\u00e4 A, Zeller T, Moilanen L, K\u00e4h\u00f6nen M, Nieminen MS et al (2011) Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes. J Intern Med 269(3):322\u2013332","journal-title":"J Intern Med"},{"issue":"4","key":"8759_CR37","doi-asserted-by":"publisher","first-page":"H2573","DOI":"10.1152\/ajpheart.00126.2007","volume":"293","author":"R Kivel\u00e4","year":"2007","unstructured":"Kivel\u00e4 R, Silvennoinen M, Lehti M, Kainulainen H, Vihko V (2007) Effects of acute exercise, exercise training, and diabetes on the expression of lymphangiogenic growth factors and lymphatic vessels in skeletal muscle. Am J Physiol Heart Circ Physiol 293(4):H2573\u2013H2579","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"8759_CR38","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","volume":"72","author":"JM Olefsky","year":"2010","unstructured":"Olefsky JM, Glass CK (2010) Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72:219\u2013246","journal-title":"Annu Rev Physiol"},{"issue":"9","key":"8759_CR39","doi-asserted-by":"publisher","first-page":"e45641","DOI":"10.1371\/journal.pone.0045641","volume":"7","author":"L Zhou","year":"2012","unstructured":"Zhou L, Cai J, Liu G, Wei Y, Tang H (2012) Associations between interleukin-1 gene polymorphisms and coronary heart disease risk: a meta-analysis. PLoS ONE 7(9):e45641","journal-title":"PLoS ONE"},{"issue":"5","key":"8759_CR40","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1471-0528.2007.01655.x","volume":"115","author":"H Singh","year":"2008","unstructured":"Singh H, Sachan R, Goel H, Mittal B (2008) Genetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancer. BJOG: Int J Obstet Gynaecol 115(5):633\u2013638","journal-title":"BJOG: Int J Obstet Gynaecol"},{"issue":"4","key":"8759_CR41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1359-6101(97)00023-3","volume":"8","author":"CA Dinarello","year":"1997","unstructured":"Dinarello CA (1997) Interleukin-1. Cytokine growth factor rev 8(4):253\u201365","journal-title":"Cytokine growth factor rev"},{"issue":"7","key":"8759_CR42","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1210\/jc.2005-2786","volume":"91","author":"L Strandberg","year":"2006","unstructured":"Strandberg L, Lorentzon M, Hellqvist A, Nilsson S, Wallenius V, Ohlsson C et al (2006) Interleukin-1 system gene polymorphisms are associated with fat mass in young men. J Clin Endocrinol Metab 91(7):2749\u20132754","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"8759_CR43","doi-asserted-by":"publisher","first-page":"5095","DOI":"10.1093\/nar\/19.18.5095","volume":"19","author":"A Steinkasserer","year":"1991","unstructured":"Steinkasserer A, Koelble K, Sim RB (1991) Length variation within intron 2 of the human IL-1 receptor antagonist protein gene (IL1RN). Nucl Acids Res 19(18):5095","journal-title":"Nucl Acids Res"},{"issue":"4","key":"8759_CR44","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/BF00217368","volume":"91","author":"JK Tarlow","year":"1993","unstructured":"Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A et al (1993) Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 91(4):403\u2013404","journal-title":"Hum Genet"},{"issue":"4","key":"8759_CR45","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1365-2370.2002.00319.x","volume":"29","author":"JE Vamvakopoulos","year":"2002","unstructured":"Vamvakopoulos JE, Taylor CJ, Morris-Stiff GJ, Green C, Metcalfe S (2002) The interleukin-1 receptor antagonist gene: a single-copy variant of the intron 2 variable number tandem repeat (VNTR) polymorphism. Eur J Immunogenet: Off J Br Soc Histocompat Immunogenet 29(4):337\u2013340","journal-title":"Eur J Immunogenet: Off J Br Soc Histocompat Immunogenet"},{"issue":"Suppl 1","key":"8759_CR46","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1471-2105-9-S1-S2","volume":"9","author":"BC Kim","year":"2008","unstructured":"Kim BC, Kim WY, Park D, Chung WH, Shin KS, Bhak J (2008) SNP@Promoter: a database of human SNPs (single nucleotide polymorphisms) within the putative promoter regions. BMC Bioinform 9(Suppl 1):S2","journal-title":"BMC Bioinform"},{"key":"8759_CR47","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.micpath.2018.03.036","volume":"118","author":"M Ghavidel","year":"2018","unstructured":"Ghavidel M, Mansury D, Nourian K, Ghazvini K (2018) The most common spoligotype of Mycobacterium bovis isolated in the world and the recommended loci for VNTR typing; a systematic review. Microb Pathog 118:310\u2013315","journal-title":"Microb Pathog"},{"issue":"5","key":"8759_CR48","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ygeno.2013.03.003","volume":"101","author":"KJ Brookes","year":"2013","unstructured":"Brookes KJ (2013) The VNTR in complex disorders: the forgotten polymorphisms? A functional way forward? Genomics 101(5):273\u2013281","journal-title":"Genomics"},{"issue":"3","key":"8759_CR49","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s100380050059","volume":"43","author":"Y Nakamura","year":"1998","unstructured":"Nakamura Y, Koyama K, Matsushima M (1998) VNTR (variable number of tandem repeat) sequences as transcriptional, translational, or functional regulators. J Hum Genet 43(3):149\u2013152","journal-title":"J Hum Genet"},{"issue":"1","key":"8759_CR50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/ng.3461","volume":"48","author":"M Gymrek","year":"2016","unstructured":"Gymrek M, Willems T, Guilmatre A, Zeng H, Markus B, Georgiev S et al (2016) Abundant contribution of short tandem repeats to gene expression variation in humans. Nat Genet 48(1):22\u201329","journal-title":"Nat Genet"},{"issue":"18","key":"8759_CR51","doi-asserted-by":"publisher","first-page":"E193","DOI":"10.1161\/01.CIR.101.18.e193","volume":"101","author":"L Iacoviello","year":"2000","unstructured":"Iacoviello L, Donati MB, Gattone M (2000) Possible different involvement of interleukin-1 receptor antagonist gene polymorphism in coronary single vessel disease and myocardial infarction. Circulation 101(18):E193","journal-title":"Circulation"},{"issue":"2","key":"8759_CR52","first-page":"503","volume":"31","author":"S Kariz","year":"2007","unstructured":"Kariz S, Milutinovi\u0107 A, Bregar D, Terzi\u0107 I, Terzi\u0107 R, Lovreci\u0107 L et al (2007) The interleukin-1 receptor antagonist gene and the inhibitor of kappa B-like protein gene polymorphisms are not associated with myocardial infarction in slovene population with type 2 diabetes. Coll Antropol 31(2):503\u2013507","journal-title":"Coll Antropol"},{"issue":"12","key":"8759_CR53","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1902\/jop.2008.070454","volume":"79","author":"K Geismar","year":"2008","unstructured":"Geismar K, Enevold C, S\u00f8rensen LK, Gyntelberg F, Bendtzen K, Sigurd B et al (2008) Involvement of interleukin-1 genotypes in the association of coronary heart disease with periodontitis. J Periodontol 79(12):2322\u20132330","journal-title":"J Periodontol"},{"issue":"1","key":"8759_CR54","first-page":"42","volume":"19","author":"O Soylu","year":"2008","unstructured":"Soylu O, Yildirim A, Coker A, Tezel T, List EO, Arman A (2008) Interleukin-1B (-511) gene polymorphism is associated with acute coronary syndrome in the turkish population. Eur Cytokine Netw 19(1):42\u201348","journal-title":"Eur Cytokine Netw"},{"issue":"5","key":"8759_CR55","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1590\/S0066-782X2008001700002","volume":"91","author":"A Arman","year":"2008","unstructured":"Arman A, Soylu O, Yildirim A, Furman A, Ercelen N, Aydogan H et al (2008) Interleukin-1 receptor antagonist gene VNTR polymorphism is associated with coronary artery disease. Arq bras de cardiol 91(5):293\u2013298","journal-title":"Arq bras de cardiol"},{"issue":"2","key":"8759_CR56","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.imlet.2010.08.003","volume":"133","author":"JM Fragoso","year":"2010","unstructured":"Fragoso JM, Delgadillo H, Llorente L, Chuquiure E, Ju\u00e1rez-Cedillo T, Vallejo M et al (2010) Interleukin 1 receptor antagonist polymorphisms are associated with the risk of developing acute coronary syndrome in Mexicans. Immunol Lett 133(2):106\u2013111","journal-title":"Immunol Lett"},{"issue":"3","key":"8759_CR57","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1744-313X.2010.00988.x","volume":"38","author":"A Coker","year":"2011","unstructured":"Coker A, Arman A, Soylu O, Tezel T, Yildirim A (2011) Lack of association between IL-1 and IL-6 gene polymorphisms and myocardial infarction in turkish population. Int J Immunogenet 38(3):201\u2013208","journal-title":"Int J Immunogenet"},{"issue":"5","key":"8759_CR58","first-page":"426","volume":"42","author":"J Gor\u0105cy","year":"2011","unstructured":"Gor\u0105cy J, Gor\u0105cy I, Safranow K, Taryma O, Adler G, Ciechanowicz A (2011) Lack of association of interleukin-1 gene cluster polymorphisms with angiographically documented coronary artery disease: demonstration of association with hypertension in the polish population. Arch Med Res 42(5):426\u2013432","journal-title":"Arch Med Res"},{"issue":"1","key":"8759_CR59","first-page":"0","volume":"19","author":"FO Mutluer","year":"2018","unstructured":"Mutluer FO, Ural D, G\u00fcng\u00f6r B, Bolca O, Aksu T (2018) Association of Interleukin-1 gene cluster polymorphisms with coronary slow flow phenomenon. Anatol J Cardiol 19(1):0","journal-title":"Anatol J Cardiol"},{"issue":"4","key":"8759_CR60","first-page":"385","volume":"27","author":"E Moosavi","year":"2020","unstructured":"Moosavi E, Enayati S, Borhan S, Mehrpooya M, Mohammad Amoli M (2020) Association of G22A variant of adenosine deaminase gene with coronary in-stent restenosis in coronary artery patients receiving drug-eluting stent. J Birjand Univ Med Sci 27(4):385\u2013391","journal-title":"J Birjand Univ Med Sci"},{"issue":"24","key":"8759_CR61","doi-asserted-by":"publisher","first-page":"5867","DOI":"10.3390\/jcm10245867","volume":"10","author":"S Ganjali","year":"2021","unstructured":"Ganjali S, Keshavarz R, Hosseini S, Mansouri A, Mannarino MR, Pirro M et al (2021) Evaluation of oxidative stress status in familial hypercholesterolemia. J Clin Med 10(24):5867","journal-title":"J Clin Med"},{"issue":"12","key":"8759_CR62","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.2337\/diabetes.51.12.3582","volume":"51","author":"R Marculescu","year":"2002","unstructured":"Marculescu R, Endler G, Schillinger M, Iordanova N, Exner M, Hayden E et al (2002) Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes. Diabetes 51(12):3582\u20133585","journal-title":"Diabetes"},{"issue":"3","key":"8759_CR63","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1136\/heart.86.3.336","volume":"86","author":"SE Francis","year":"2001","unstructured":"Francis SE, Camp NJ, Burton AJ, Dewberry RM, Gunn J, Stephens-Lloyd A et al (2001) Interleukin 1 receptor antagonist gene polymorphism and restenosis after coronary angioplasty. Heart 86(3):336\u2013340","journal-title":"Heart"},{"issue":"1","key":"8759_CR64","first-page":"54","volume":"88","author":"B Vohnout","year":"2003","unstructured":"Vohnout B, Di Castelnuovo A, Trotta R, D\u2019Orazi A, Panniteri G, Montali A et al (2003) Interleukin-1 gene cluster polymorphisms and risk of coronary artery disease. Haematologica 88(1):54\u201360","journal-title":"Haematologica"},{"issue":"4","key":"8759_CR65","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1177\/1470320315588233","volume":"16","author":"HW Miao","year":"2015","unstructured":"Miao HW, Gong H (2015) Association of ACE insertion or deletion polymorphisms with the risk of coronary restenosis after percutaneous coronary intervention: a meta-analysis. J Ren-Angiotensin-Aldosterone Syst 16(4):844\u2013850","journal-title":"J Ren-Angiotensin-Aldosterone Syst"},{"issue":"2","key":"8759_CR66","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1084\/jem.191.2.313","volume":"191","author":"R Horai","year":"2000","unstructured":"Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A et al (2000) Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 191(2):313\u2013320","journal-title":"J Exp Med"},{"key":"8759_CR67","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1744-9081-7-23","volume":"7","author":"D Sasayama","year":"2011","unstructured":"Sasayama D, Hori H, Iijima Y, Teraishi T, Hattori K, Ota M et al (2011) Modulation of cortisol responses to the DEX\/CRH test by polymorphisms of the interleukin-1beta gene in healthy adults. Behav Brain Functions: BBF 7:23","journal-title":"Behav Brain Functions: BBF"},{"issue":"2","key":"8759_CR68","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1080\/13547500500525383","volume":"11","author":"PK Manchanda","year":"2006","unstructured":"Manchanda PK, Kumar A, Bid HK, Mittal RD (2006) Interleukin-1beta and receptor antagonist (IL-1Ra) gene polymorphisms and the prediction of the risk of end-stage renal disease. Biomarkers 11(2):164\u2013173","journal-title":"Biomarkers"},{"issue":"4","key":"8759_CR69","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1084\/jem.173.4.931","volume":"173","author":"KW McIntyre","year":"1991","unstructured":"McIntyre KW, Stepan GJ, Kolinsky KD, Benjamin WR, Plocinski JM, Kaffka KL et al (1991) Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J Exp Med 173(4):931\u2013939","journal-title":"J Exp Med"},{"issue":"5","key":"8759_CR70","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.urology.2005.11.032","volume":"67","author":"HK Bid","year":"2006","unstructured":"Bid HK, Manchanda PK, Mittal RD (2006) Association of interleukin-1Ra gene polymorphism in patients with bladder cancer: case control study from North India. Urology 67(5):1099\u20131104","journal-title":"Urology"},{"issue":"2","key":"8759_CR71","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1086\/338261","volume":"34","author":"SS Witkin","year":"2002","unstructured":"Witkin SS, Gerber S, Ledger WJ (2002) Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Diseases: Official Publication Infect Dis Soc Am 34(2):204\u2013209","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"5","key":"8759_CR72","first-page":"1141","volume":"86","author":"RY Zee","year":"2001","unstructured":"Zee RY, Lunze K, Lindpaintner K, Ridker PM (2001) A prospective evaluation of the interleukin-1 receptor antagonist intron 2 gene polymorphism and the risk of myocardial infarction. Thromb Haemost 86(5):1141\u20131143","journal-title":"Thromb Haemost"},{"issue":"3","key":"8759_CR73","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1161\/01.STR.0000057815.79289.EC","volume":"34","author":"BB Worrall","year":"2003","unstructured":"Worrall BB, Azhar S, Nyquist PA, Ackerman RH, Hamm TL, DeGraba TJ (2003) Interleukin-1 receptor antagonist gene polymorphisms in carotid atherosclerosis. Stroke 34(3):790\u2013793","journal-title":"Stroke"},{"issue":"9","key":"8759_CR74","first-page":"825","volume":"44","author":"A Manzoli","year":"1999","unstructured":"Manzoli A, Andreotti F, Varlotta C, Mollichelli N, Verde M, van de Greef W et al (1999) Allelic polymorphism of the interleukin-1 receptor antagonist gene in patients with acute or stable presentation of ischemic heart disease. Cardiologia (Rome Italy) 44(9):825\u2013830","journal-title":"Cardiologia (Rome Italy)"},{"issue":"2","key":"8759_CR75","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1056\/NEJM199801083380202","volume":"338","author":"L Iacoviello","year":"1998","unstructured":"Iacoviello L, Di Castelnuovo A, De Knijff P, D\u2019Orazio A, Amore C, Arboretti R et al (1998) Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med 338(2):79\u201385","journal-title":"N Engl J Med"},{"issue":"5","key":"8759_CR76","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/1043-4666(93)90035-4","volume":"5","author":"H Rokita","year":"1993","unstructured":"Rokita H, Neta R, Sipe JD (1993) Increased fibrinogen synthesis in mice during the acute phase response: co-operative interaction of interleukin 1, interleukin 6, and interleukin 1 receptor antagonist. Cytokine 5(5):454\u2013458","journal-title":"Cytokine"},{"issue":"4","key":"8759_CR77","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S0016-5085(99)70338-0","volume":"117","author":"NA Tountas","year":"1999","unstructured":"Tountas NA, Casini-Raggi V, Yang H, Di Giovine FS, Vecchi M, Kam L et al (1999) Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology 117(4):806\u2013813","journal-title":"Gastroenterology"},{"issue":"6","key":"8759_CR78","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/BF02346180","volume":"97","author":"FE Clay","year":"1996","unstructured":"Clay FE, Tarlow JK, Cork MJ, Cox A, Nicklin MJ, Duff GW (1996) Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment. Hum Genet 97(6):723\u2013726","journal-title":"Hum Genet"},{"issue":"2","key":"8759_CR79","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2249.1995.tb05549.x","volume":"99","author":"VA Danis","year":"1995","unstructured":"Danis VA, Millington M, Hyland VJ, Grennan D (1995) Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 99(2):303\u2013310","journal-title":"Clin Exp Immunol"},{"issue":"6776","key":"8759_CR80","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/35006081","volume":"404","author":"EM El-Omar","year":"2000","unstructured":"El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA et al (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404(6776):398\u2013402","journal-title":"Nature"},{"issue":"3","key":"8759_CR81","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1046\/j.1365-3083.1998.00300.x","volume":"47","author":"S Santtila","year":"1998","unstructured":"Santtila S, Savinainen K, Hurme M (1998) Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 47(3):195\u2013198","journal-title":"Scand J Immunol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08759-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-023-08759-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08759-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T15:22:00Z","timestamp":1695655320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-023-08759-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":81,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["8759"],"URL":"https:\/\/doi.org\/10.1007\/s11033-023-08759-w","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,29]]},"assertion":[{"value":"13 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All protocols used in human subject studies were carried out in accordance with the institutional and\/or national Research Committee\u2019s ethical standards, as well as the 1964 Helsinki Declaration and its later amendments or similar ethical principles. The Ethics Committee of the Endocrine and Metabolic Research Institute (EMRI) approved this study (IR.TUMS.IKHC.REC.1401.170).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All individuals who participated in the study gave their informed permission before participation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}